Posted by on June 19, 2013 - 2:53pm

The pro-life v. pro-choice debate continued on the House floor yesterday as party representatives grappled with sustaining women’s reproductive rights in a surfacing abortion bill.  On Tuesday, the House of Representatives approved a bill banning a woman’s right to pursue an abortion after 22 weeks of pregnancy, subtracting two weeks off the current cut-off of abortions at 24 weeks in utero.  The majority-Republican party passed this bill shaving off the extra two weeks based off the medically disputed theory that a fetus is capable of feeling pain 20 weeks after conception (which is equivalent to 22 weeks of pregnancy).  Democrats in the House and the White House fought against the bill, saying the legislation is an “assault on a woman’s right to choose” and is an attempt to undermine the precedent set in the 1973 Roe v. Wade trial.

The argument quickly split down party lines (only six party members from each side voting against their party) and escalated into a debate on women’s reproductive rights.  In this heated bipartisan debate, representatives from both sides evoked emotional appeals.  Though different in message, consistent across both lines is the lack of the female voice.  While the House attempted to integrate more women in this debate, only 19 of the 222 Republican House members who voted for this bill are women.  In total, the House of Representatives only has 78 women, accounting for a meager 18% voice in the House.  Furthermore, there are no Republican women on the Judiciary Committee panel that has jurisdiction over this particular legislation.

While this bill certainly made headlines, the threat of it obtaining further approval is low.  Sources agree that the bill will not find support in the Democrat-controlled Senate, and President Obama has also already voiced his opposition.  Although no abortion laws are changing today, it is important to keep abreast on the dialogue surrounding this controversial and emotional topic.  Most importantly, government representatives must do a better job of allowing women’s voices and opinions to be heard.  Female reproductive rights issues have been considered taboo for too long, and an open dialogue in the government may help bridge the gap between women and policy.

Sources: ABC News, USA Today, and The New York Times.

 

Posted by on June 19, 2013 - 8:56am

Geneticists, researchers, and patients joined in celebration over last week’s unanimous Supreme Court ruling involving the BRCA1 and BRCA2 genes, colloquially referred to as the “breast cancer genes.”  The Supreme Court ruled that Myriad Genetics could not patent the BRCA1 and BRCA2 sequence of genes, because patents cannot be placed on that which is created organically in nature.  This decision opens the door for researchers outside of Myriad Genetics to study these genes, providing more opportunities to discover early signs of breast cancer susceptibility.  Karuna Jaggar, Breast Cancer Action’s Executive Director reported that this ruling was, “a tremendous victory for women with a known or suspected inherited risk of breast cancer. Today, the Court righted a wrong and has put patients’ health before corporate profits.”

Prior to this ruling, bio-tech conglomerate, Myriad Genetics, held patents on the BRCA1 and BRCA2 genes, monopolizing the research that can be done on these genes, which are strong indicators of susceptibility to breast cancer. Myriad had used their patents to come up with its BRACAnalysis test, which searches for specific mutations in these cancer predisposition genes.  Women who show these mutations have a three to seven times greater risk of developing breast cancer.  Myriad’s previously established patents on these genes gave them exclusive rights to use this genetic test on these genes.  Now that the BRCA1 and BRCA2 genes are open to outside researchers, scientists can use these genes to determine increased risks of patients who may develop breast cancer, ovarian cancer, and other cancers that these genes may help indicate.

Angelina Jolie recently made headlines for deciding to voluntarily undergo a double mastectomy after learning of her own BRCA genes' mutations.  Jolie had paid a high price for this test, since Myriad had a monopoly on the market, driving up the cost.  So what does this mean for the average, non-Angelina Jolie woman? Well, now this test will be widely available for more women at a more affordable price (we don’t all have as deep of pockets as Jolie).  This ruling will not only open the door for more opportunities for preventative screenings for breast cancer, but it will set a precedent for the scientific community to collaborate on research towards the common good.

For more information on this court ruling, please refer to this posts's sources found here and here.

 

Posted by on June 18, 2013 - 10:39am

 

Policy changes are necessary to decrease the death rate of pregnant women in developing countries.  Research, according to Dr. Stacie E. Geller, does not end once scientists publish.  The true battle is implementing that research to affect global change.  Dr. Stacie E. Geller, Director of the Center for Research on Women and Gender at the University of Illinois at Chicago College of Medicine, puts research into practice by providing safe, affordable medication to pregnant women in developing countries.  Dr. Geller spoke last week at a forum held at Northwestern University's Feinberg School of Medicine and presented her research on Postpartum Hemorrhaging (PPH) and its dangers to women in developing countries.

In 2008, there were an estimated 358,000 maternal deaths occurring during childbirth, 99% of these deaths occurring in developing countries. Such global disparities are reflected in the limited access to skilled birth attendants, restricted access to medications, rudimentary delivery facilities, and complications surrounding reliable transportation and communication in developing countries.  Postpartum Hemorrhaging (PPH) is the leading cause of maternal mortality worldwide, accounting for 30-50% of all maternal deaths in Africa and Asia alone.  While the drug Oxytocin is used to prevent PPH in developed countries, developing countries do not have the resources to preserve and administer this drug.  Dr. Geller began studying the drug Misoprostol as an alternative to Oxytocin to be used in developing countries due to its low-maintenance storage and cost-effectiveness.

Dr. Geller, along with a team of researchers traveled to communities in India and Ghana to study Misoprostol for prevention of PPH in home-birth settings.  Their research proved that Misoprostol provides a safe and efficacious alternative to Oxytocin in these communities, but Dr. Geller didn’t stop there.  She worked with the Indian Ministry of Health to approve the use of Misoprostol for PPH prevention by Auxillary Nurse Midwives (ANMs). In Ghana, Dr. Geller engaged with health stakeholders at all levels, conducted community sensitization and trainings, monitored the safe use of Misoprostol, and empowered women to take control of their health.  Furthermore Dr. Gellar’s success strengthened the networks of health providers, decreased maternal mortality and morbidity (due to PPH), and established a model for all of Ghana and other developing countries.  Dr. Geller was a primary advocate credited for Misoprostol’s addition to the WHO’s list of essential medications for the prevention of PPH in 2011, an accreditation which has a lasting global impact.

Dr. Geller stresses the importance of political will in enacting policy changes from scientific research.  Government engagement is critical in reducing maternal deaths, and a scientist’s work is not over once research is published.  Advocating for women’s sexual and reproductive rights, their access to equal treatment, and their right to effective medicine should inspire all researchers to utilize their knowledge to facilitate global change.

To read more about Dr. Stacie Geller and her ongoing research, please click here.

 

Posted by on June 13, 2013 - 3:37pm

Did you know that most adverse drug side effects that are reported are done so by women?  This is why we advocate so strongly for the inclusion of males AND females in all animal and human drug studies.  It's important that consumers report any bad experiences to the FDA!

A new consumer-friendly form is now available for making reports to MedWatch, FDA's on-line system for collecting information about serious problems with drugs, medical devices and other FDA-regulated products.

The less technical form is part of a larger effort to encourage consumers to submit quality reports. By reporting your experience or suspicion of a product problem to MedWatch, you could help identify an unknown risk and potentially spark a variety of actions—from changes to a warning label to removal of the product from the market.
Read this Consumer Update to learn more about what FDA is doing to increase consumer participation in MedWatch.

Posted by on June 13, 2013 - 10:10am

Don't watch what you eat, instead, THINK about it. Recent studies in an article in Gastroenterology (June) has shown that probiotics, often found in yogurt, can actually affect brain activity. Yogurt in the US has now grown to place 20 and 21st in the top 50 most eaten and recommended "snack foods", but how much do we really know about the affects of eating it, other than how many calories there are.

The study was only observed in women, 36  to be exact with no history of gastrointestinal or psychiatric symptoms. These women were given fMRI'S before and after the 4 week study period. During this period 12 women ate the fermented yogurt (containing probiotics), 11 ate nonfermented, and 13 were not given specifics. After several tasks to study results, the study showed that women in the probiotic group did show more differences in emotion and sensation response.

Simply because the results showed changes in brain activity does NOT mean probiotics are harmful. So do not be alarmed! The study did not show a positive or negative correlation with brain activity and future studies are in the plans. The affects in brain activity were also due to the constant exposure to probiotics. With this new first in its field discovery the study hopes to perhaps some day bring treatment options to neurological and mental diseases one snack at a time!

To learn nutritional and dietary information about yogurt click here

 

Posted by on June 11, 2013 - 9:46am

Think men and women receive equal care after traumas? Think again.  A recent study found that women are less likely than men to receive trauma treatment after severe injuries.  Dr. Andrea Hill of the Sunnybrook Health Sciences Centre and the University of Toronto’s research on gender-based inequalities found that, across all age groups, 20-30% fewer women are cared for after traumas.  The study and analysis were conducted by observing 99,000 adult patients throughout Canada.  After controlling for demographic and socioeconomic factors, Hill and her colleagues were shocked at such disproportions between male and female patient care.  Hill affirms that “gender-based disparities in access to health care services in general have been recognized for some time,” and she calls for further research into the underlying factors involved in these gender gaps.

 

To read more about this issue, please view the original article here.

 

Posted by on June 4, 2013 - 3:25pm

I think women want to feel independent, that we can conquer the world on our own.  Sometimes it can be hard to ask for help.

Having issues getting pregnant can be one of those times.  Most of us assume that it’s easy; you get off birth control, have sex, and you're pregnant! However, for many women, especially those who delay their first pregnancy until they are older,  getting pregnant can be anything but easy.

Struggling to get pregnant and going through infertility treatments is stressful; it can be a lonely time.  No one should have to go through it alone!

Support groups can be an amazing resource for women while on their infertility journey.  It can be therapeutic to open up and share your feelings and your fears with peers who understand and are going through the same experience.

My own personal journey through infertility inspired me to create a unique support community called Shine (www.shinechicago.com);  group sessions combine peer support as well as professional guest speakers from the women’s health community.

From my own experience, I can say first hand how important support is while going through a difficult time.  Your partner is your first layer of support, but it can be helpful and healthy to have another place to turn, both for your own emotional health and the health of your relationship.

So know it’s okay to be vulnerable, it’s okay to reach out for help, it’s okay to open up about your story!  One of my favorite quotes relates so well to infertility: “strength doesn’t come from what you can do, it comes from overcoming the things you once thought you couldn’t.”

Guest blogger: Katie O'Connor (Founder, Shine Chicago: a ray of light on infertility)

Posted by on May 31, 2013 - 8:09am

Did you know that 15% of women are diagnosed with Hypoactive Sexual-Desire Disorder (H.S.D.D)?  This disorder is characterized by a lack of female desire coupled with significant emotional distress, primarily in post-menopausal women.  A recent article in The New York Times placed Dutch psychopharmacologist Adriaan Tuiten in the spotlight for his new research studies on sex differences.  Tuiten, who has spent his career studying biological and psychological interactions, may have unlocked some the intricacies of female desire via his study on possibly the first, successful female-desire drug.

The publicized misnomer that this drug will be a “female Viagra” simplifies its actual complexity.  Ongoing studies in this field since 1998 unequivocally show that the male and female impetus for desire differs significantly, especially in the brain.  While both male and female desire stem from similar areas of the brain, studies show that, over time, female desire wanes at a significantly higher rate than observed in males.

How can women combat this atrophy of desire?  Tuiten tested and observed 420 female subjects beginning in the fall of 2011 to answer just that.  His drugs Lybrido and Lybridos are expected to be presented shortly to the F.D.A., and may be on the market by 2016 following a larger-scale trial.

Guest Author:  Megan Castle

 

 

 

Posted by on May 29, 2013 - 9:47am

Breasts—especially those that scale towards the large end of the spectrum—are often named as a scapegoat for back pain in women. However, it’s likely that much of the blame is misplaced. This misdirected implication could be leading women to false self-diagnoses and even unnecessary medical procedures.

Many women experience back pain and, without a more apparent culprit to blame, turn to those (literally) right under their noses. It’s not surprising that people want to point the finger at breasts as back pain contributors. After all, it seems intuitive to think that bulky weights attached to the upper torso would throw the entire body off balance and put extra stress on the spine and muscles that support it. When considering that these weights are present through every moment of every day of your life, and suddenly this seems like a very logical diagnosis.

In reality, though, breasts are rarely the primary contributor to most varieties of back pain. The human back, when healthy and normal, is more than strong enough to support even a fairly large chest through the years. Instead, there are many more common factors that cause back pain in women such as

  • Obesity that causes undue and constant stress to the entire body
  • Pregnancy and the related physiological changes
  • Non-optimal bra size
  • Chronic poor posture
  • Injury or overexertion of the muscles or bones in the back
  • Irritation of spinal nerves through disc herniation or bulging
  • A weakening of the spine through osteoporosis and similar conditions

Compared to these pain originators, breasts are much less likely to cause a painful condition themselves. However, they can exacerbate an existing condition. Breasts can make bad posture worse, will add additional stress to pulled muscles, and make it harder for injured discs to heal.

There are some steps women can take to avoid or remedy back pain that could be contributed to by the weight of breasts. The most important is to keep as healthy of a body overall as possible through diet and exercise. This will help ensure a strong back which will be able to easily support breast weight and more. It will keep weight at a manageable level to reduce excess stress on muscles and joints, and speed healing from any injuries. Care must be taken to avoid overexertion like strains and sprains, which cause pain more directly.

In some cases, it’s possible that a woman’s breasts are a primary cause for her back pain. This happens most frequently when a relatively small person has disproportionately large breasts. A reduction surgery may be recommended by doctors if the breasts are causing chronic pain and compromising the woman’s happiness. Back pain can also occur after a time a rapid breast size increase, like after a breast augmentation surgery. Over time this pain usually fades as the body adjusts to the new size, but a reduction or reversal of the surgery may also be recommended if the pain is persistent.

Women have, understandably, blamed breasts for unexplained back pain. Before jumping to conclusions or turning to extreme treatments, however, they should always be careful to consider more likely culprits than those on their chests first.

Guest Author Jamie Arnold is a staff writer & content editor for www.BackPainRelief.net. Jamie is also a yoga enthusiast, animal lover and avid traveler who loves to blog about health, fitness, and back pain relief.

 

 

 

Posted by on May 27, 2013 - 9:06am

A significant number of parents are not allowing their daughters to receive the HPV (human papilloma virus) vaccine, despite an increase in doctors recommending it. The HPV vaccine is a series of three shots given to pre-teen and teen girls and boys over the course of six months to prevent HPV and related conditions, most notably, cervical cancer in women.

Between 2008 and 2010, the percentage of doctors recommending the HPV vaccine rose from 48% to 52%. However, the CDC reports that only around one-third of eligible girls have received the HPV vaccine. In a study of parents not planning on having their daughters receive the vaccine, the percentage of those concerned about its safety increased from 5% to 16% over the course of three years. Another 17% cited the lack of necessity of the vaccine as the reason their daughters won’t receive it.

In response to concerns over the safety of the HPV vaccine, Dr. Joseph Bocchini, a pediatrician on the CDC’s Advisory Committee on Immunization Practices has stated that “we have not identified a significant likelihood of serious adverse events following vaccine” and that it “is a very safe vaccine.” Claims that the vaccine is not necessary appear weak after identifying what results from HPV. Nearly all instances of cervical cancer are caused by HPV, and many cases of vulvar and vaginal cancer are linked to it. This doesn’t mean men are exempt from HPV. 95% of anal cancers and 60% of oropharyngeal cancers (cancers in back of the throat, base of the tongue and tonsils) are caused by HPV. Vaccinating both boys and girls significantly reduces the risk of them having several forms of cancer in the future.

Increasing education efforts may help increase the rate in which children receive the HPV vaccine. Currently, there is a strong correlation between receiving a doctor’s recommendation and receiving the vaccine. However, many teens do not see a primary care provider regularly in the years they can be vaccinated. Additionally, parents may not know about the vaccine, or feel they don’t know enough about it and how it can help their children. To tackle these problems, education programs that target the general public are necessary.

For more information on the HPV vaccine, click here.

 

Sources:

Hensley, Scott. "Worried Parents Balk at HPV Vaccine for Daughters." NPR. 18 March 2013.
"HPV and Cancer." Centers for Disease Control and Prevention. 5 February 2013. 

Pages